Disclosures for "Safety and Efficacy of Oral Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine in the Pediatric Population")
-
Dr. Tourlas has stock in Axonics Modulation Technologies (AXNX). Dr. Tourlas has stock in Biote (BTMD).
-
An immediate family member of Dr. Pavitt has received personal compensation for serving as an employee of Lundbeck.